TRL 382Alternative Names: TR-L-382
Latest Information Update: 24 Mar 2016
At a glance
- Originator Toray
- Mechanism of Action Cyclo-oxygenase 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 24 Mar 2016 Discontinued - Preclinical for Neuropathic pain in Japan (PO)
- 21 Oct 2009 Preclinical trials in Neuropathic pain in Japan (PO)